Oocyte vitrification for elective fertility preservation: a SWOT analysis

Elisa Gil-Arribas, Christophe Blockeel, Guido Pennings, Julie Nekkebroeck, Juan A García Velasco, José Serna, Michel De Vos

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Oocyte vitrification, also known as egg freezing, is increasingly being used by women as a precautionary measure against the anticipated decline in fertility. In countries where this procedure is allowed, elective oocyte vitrification has become an integral part of the treatment portfolio of fertility clinics. The widespread tendency towards the postponement of motherhood and the advances in laboratory technologies are encouraging women to consider oocyte vitrification and, by doing so, increase their reproductive autonomy. However, elective oocyte vitrification, or elective egg freezing (EEF), still elicits controversy, not only when EEF is appraised from a cost-efficiency point of view, but also in terms of medical and ethical concerns. In general, although the laboratory tool of vitrification has revolutionized the treatment of infertility, the pros and cons need to be clarified when considering EEF.

Original languageEnglish
Pages (from-to)1005-1014
Number of pages10
JournalReproductive Biomedicine Online
Issue number6
Early online date5 Feb 2022
Publication statusPublished - Jun 2022

Bibliographical note

Copyright © 2022 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.


  • Egg freezing
  • Female emancipation
  • Fertility preservation
  • Oocyte cryopreservation
  • Social fertility preservation
  • Vitrification


Dive into the research topics of 'Oocyte vitrification for elective fertility preservation: a SWOT analysis'. Together they form a unique fingerprint.

Cite this